QUCY Mainz Biomed N.V.
Healthcare$3.33-6.46%ClosedMarket Cap: $41.7M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
8.56
P/S
145.36
EV/EBITDA
-4.97
DCF Value
$-2.06
FCF Yield
-13.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-2723.5%
Net Margin
-2937.8%
ROE
-244.2%
ROA
-109.1%
ROIC
-165.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $0.00 | $-5.1M | $— |
| FY null | $537.1K | $-16.2M | $— |
| Q2 null | $286.7K | $-3.3M | $— |
| FY null | $894.0K | $-21.7M | $— |
Analyst Ratings
View AllConsensus
Hold
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell
Trading Activity
Insider Trades
View AllO'Rourke Peterdirector
SellThu May 21
NATAN DAVIDdirector
SellTue Apr 28
Ben-Tzvi Avrahamdirector
SellTue Apr 28
Company Info
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
DE
Exchange
—
Beta
0.43
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.